Paper summarising the decision made at a meeting held on 9 February 2004 at the Department of Health in London which included the creation of a group to be titled The Forward Planning and Monitoring Group for Rollout of Recombinant Treatment for Adult Haemophilia Patients. Additional decisions made included how funding would be distributed, how Audit procedures would work and when the newly created group would meet.